Palogic Value Management’s AbbVie ABBV Stock Holding History

Palogic Value Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.66M	Hold	18,505	–	–	1.53%	12
2026 Q1	$4.02M	Sell	18,505 -675	-4%	-$150K	1.7%	12
2025 Q4	$4.38M	Hold	19,180	–	–	1.83%	11
2025 Q3	$4.44M	Hold	19,180	–	–	1.79%	12
2025 Q2	$3.56M	Sell	19,180 -20	-0.1%	-$3.72K	1.45%	18
2025 Q1	$4.02M	Hold	19,200	–	–	1.74%	12
2024 Q4	$3.41M	Hold	19,200	–	–	1.29%	23
2024 Q3	$3.79M	Hold	19,200	–	–	1.29%	16
2024 Q2	$3.29M	Hold	19,200	–	–	1.4%	20
2024 Q1	$3.5M	Hold	19,200	–	–	1.51%	17
2023 Q4	$2.98M	Hold	19,200	–	–	1.32%	22
2023 Q3	$2.86M	Hold	19,200	–	–	1.36%	18
2023 Q2	$2.59M	Sell	19,200 -300	-2%	-$44K	1.21%	21
2023 Q1	$3.11M	Hold	19,500	–	–	1.52%	15
2022 Q4	$3.15M	Buy	+19,500	New	+$2.99M	1.64%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Palogic Value Management's ABBV Position: Q2 2026 in Review

Palogic Value Management held its AbbVie (ABBV) position steady in Q2 2026 at 18,505 shares worth $4.66M. The position accounts for 1.53% of the portfolio, ranked #12.

Palogic Value Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Palogic Value Management held 18,505 shares of AbbVie worth $4.66M as of Q2 2026.
Palogic Value Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.53% of Palogic Value Management's portfolio in Q2 2026, its #12 holding.
Palogic Value Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.